ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,304.72
0.70%
US Tech 100
18,318.00
0.95%
다우존스 지수
39,069.59
0.01%
Bitcoin
68,876.94
-0.57%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Amryt Pharma PLC (AMYT)

  7. Amryt Pharma PLC (AMYT) 뉴스

AMYT

Amryt Pharma (AMYT)

Amryt Pharma PLC
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AMYT
일자시간출처헤드라인심볼기업
2023/04/1906:02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AMYTAmryt Pharma PLC
2023/04/1906:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AMYTAmryt Pharma PLC
2023/04/1905:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMYTAmryt Pharma PLC
2023/04/1306:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
2023/04/1221:21Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:AMYTAmryt Pharma PLC
2023/04/1220:58PR Newswire (US)Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma PlcNASDAQ:AMYTAmryt Pharma PLC
2023/04/1220:00GlobeNewswire Inc.Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma PlcNASDAQ:AMYTAmryt Pharma PLC
2023/04/1122:00GlobeNewswire Inc.2022 for Chiesi: The Group’s international growth continuesNASDAQ:AMYTAmryt Pharma PLC
2023/04/0322:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
2023/03/2322:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
2023/02/1621:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
2023/02/1400:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMYTAmryt Pharma PLC
2023/02/1106:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMYTAmryt Pharma PLC
2023/02/1023:49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMYTAmryt Pharma PLC
2023/01/1006:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
2022/11/0712:35TipRanksSVB Securities Keeps Their Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
2022/11/0503:55TipRanksAmryt Pharma (AMYT) Receives a Buy from Maxim GroupNASDAQ:AMYTAmryt Pharma PLC
2022/11/0419:25TipRanksAmryt Pharma (AMYT) Receives a Buy from H.C. WainwrightNASDAQ:AMYTAmryt Pharma PLC
2022/11/0320:45Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
2022/09/1919:25TipRanksH.C. Wainwright Sticks to Its Buy Rating for Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
2022/08/0821:27TipRanksH.C. Wainwright Keeps Their Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
2022/08/0602:25TipRanksMaxim Group Reiterates a Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
2022/07/1420:49Dow Jones NewsAmryt Gets FDA Orphan Designation for Mycapssa in Carcinoid SyndromeNASDAQ:AMYTAmryt Pharma PLC
2022/06/2616:39TipRanksSVB Securities Keeps a Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
2022/06/2420:54Dow Jones NewsAmryt to Pursue Formal FDA Resolution for Oleogel-S10NASDAQ:AMYTAmryt Pharma PLC
2022/06/2420:19Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
2022/06/2320:26Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
2022/05/2319:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AMYTAmryt Pharma PLC
2022/05/2106:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:AMYTAmryt Pharma PLC
2022/05/2105:59Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:AMYTAmryt Pharma PLC
 검색 관련기사 보기:NASDAQ:AMYT

최근 히스토리

USOTC
ZNNC
Zann (CE)
NYSE
CATO
Cato
COIN
XLPEUR
BIT
S29000
Societe Generale Effekten
BIT
BOTZ
Global X Robotics & Arti...
BIT
F17046
Vontobel Financial Produ...
BIT
UIJ781
Unicredit Bank
LSE
LTMU
Ly Emlane Ac U
ASX
TNRN
NYSE
SNPR.U
Tortoise Acquisition Cor...
HUOB
CVCUSDT
Civic
COIN
LTHNETH
ASX
CWNKOB
EU
INLEM
Lyxor LEM Inav
LSE
WOSC
Spdr Wrld Small
NASDAQ
WWTAJX
Wilmington Trust TRowe P...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유